conotoxin-gv and Nerve-Degeneration

conotoxin-gv has been researched along with Nerve-Degeneration* in 1 studies

Other Studies

1 other study(ies) available for conotoxin-gv and Nerve-Degeneration

ArticleYear
Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis.
    European journal of pharmacology, 2002, Sep-27, Volume: 452, Issue:1

    Staurosporine-induced apoptosis was associated with a 20% cellular survival rate in primary rat forebrain cultures. Treatment with the NR2B subunit-selective NMDA receptor antagonist conantokin-G (0.1-1 microM) increased the survival rate up to 78%. No protection was provided by the nonselective NMDA receptor antagonist dizocilpine (0.01-10 microM) but 34-64% cellular survival was provided by ifenprodil (0.01-10 microM), another NR2B subunit-selective antagonist. These results suggest a novel anti-apoptotic mechanism linked to the NR2B receptor subunit.

    Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; Conotoxins; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Nerve Degeneration; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Staurosporine

2002